163 related articles for article (PubMed ID: 30503777)
1. Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer.
Wu P; Sneeringer CJ; Pitts KE; Day ES; Chan BK; Wei B; Lehoux I; Mortara K; Li H; Wu J; Franke Y; Moffat JG; Grogan JL; Heffron TP; Wang W
Structure; 2019 Jan; 27(1):125-133.e4. PubMed ID: 30503777
[TBL] [Abstract][Full Text] [Related]
2. Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation.
Johnson E; McTigue M; Gallego RA; Johnson TW; Timofeevski S; Maestre M; Fisher TS; Kania R; Sawasdikosol S; Burakoff S; Cronin CN
J Biol Chem; 2019 Jun; 294(23):9029-9036. PubMed ID: 31018963
[TBL] [Abstract][Full Text] [Related]
3. HPK1 citron homology domain regulates phosphorylation of SLP76 and modulates kinase domain interaction dynamics.
Chitre AS; Wu P; Walters BT; Wang X; Bouyssou A; Du X; Lehoux I; Fong R; Arata A; Chan J; Wang D; Franke Y; Grogan JL; Mellman I; Comps-Agrar L; Wang W
Nat Commun; 2024 May; 15(1):3725. PubMed ID: 38697971
[TBL] [Abstract][Full Text] [Related]
4. The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function.
Hernandez S; Qing J; Thibodeau RH; Du X; Park S; Lee HM; Xu M; Oh S; Navarro A; Roose-Girma M; Newman RJ; Warming S; Nannini M; Sampath D; Kim JM; Grogan JL; Mellman I
Cell Rep; 2018 Oct; 25(1):80-94. PubMed ID: 30282040
[TBL] [Abstract][Full Text] [Related]
5. The Structure of HPK1 Kinase Domain: To Boldly Go Where No Immuno-Oncology Drugs Have Gone Before.
Sawasdikosol S; Burakoff S
Structure; 2019 Jan; 27(1):1-3. PubMed ID: 30605659
[TBL] [Abstract][Full Text] [Related]
6. Interactions between hematopoietic progenitor kinase 1 and its adaptor proteins (Review).
Zhang Q; Ding S; Zhang H
Mol Med Rep; 2017 Nov; 16(5):6472-6482. PubMed ID: 28901492
[TBL] [Abstract][Full Text] [Related]
7. Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascade.
Hu MC; Qiu WR; Wang X; Meyer CF; Tan TH
Genes Dev; 1996 Sep; 10(18):2251-64. PubMed ID: 8824585
[TBL] [Abstract][Full Text] [Related]
8. Discovery of an Allosteric, Inactive Conformation-Selective Inhibitor of Full-Length HPK1 Utilizing a Kinase Cascade Assay.
Wang W; Mevellec L; Liu A; Struble G; Miller R; Allen SJ; Federowicz K; Wroblowski B; Vialard J; Ahn K; Krosky D
Biochemistry; 2021 Oct; 60(41):3114-3124. PubMed ID: 34608799
[TBL] [Abstract][Full Text] [Related]
9. B cell adaptor containing src homology 2 domain (BASH) links B cell receptor signaling to the activation of hematopoietic progenitor kinase 1.
Tsuji S; Okamoto M; Yamada K; Okamoto N; Goitsuka R; Arnold R; Kiefer F; Kitamura D
J Exp Med; 2001 Aug; 194(4):529-39. PubMed ID: 11514608
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes.
Ma W; Xia C; Ling P; Qiu M; Luo Y; Tan TH; Liu M
Oncogene; 2001 Mar; 20(14):1703-14. PubMed ID: 11313918
[TBL] [Abstract][Full Text] [Related]
11. Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor of NFkappaB.
Arnold R; Liou J; Drexler HC; Weiss A; Kiefer F
J Biol Chem; 2001 May; 276(18):14675-84. PubMed ID: 11278403
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 4 is a positive regulator of hematopoietic progenitor kinase 1.
Zhou G; Boomer JS; Tan TH
J Biol Chem; 2004 Nov; 279(47):49551-61. PubMed ID: 15364934
[TBL] [Abstract][Full Text] [Related]
13. Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.
Arnold R; Patzak IM; Neuhaus B; Vancauwenbergh S; Veillette A; Van Lint J; Kiefer F
Mol Cell Biol; 2005 Mar; 25(6):2364-83. PubMed ID: 15743830
[TBL] [Abstract][Full Text] [Related]
14. The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for Immunotherapy.
Malchow S; Korepanova A; Panchal SC; McClure RA; Longenecker KL; Qiu W; Zhao H; Cheng M; Guo J; Klinge KL; Trusk P; Pratt SD; Li T; Kurnick MD; Duan L; Shoemaker AR; Gopalakrishnan SM; Warder SE; Shotwell JB; Lai A; Sun C; Osuma AT; Pappano WN
ACS Chem Biol; 2022 Mar; 17(3):556-566. PubMed ID: 35188729
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of domain-swapped STE20 OSR1 kinase domain.
Lee SJ; Cobb MH; Goldsmith EJ
Protein Sci; 2009 Feb; 18(2):304-13. PubMed ID: 19177573
[TBL] [Abstract][Full Text] [Related]
16. Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations.
Ge H; Tang C; Pan Y; Yao X
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768974
[TBL] [Abstract][Full Text] [Related]
17. HPK1 competes with ADAP for SLP-76 binding and via Rap1 negatively affects T-cell adhesion.
Patzak IM; Königsberger S; Suzuki A; Mak TW; Kiefer F
Eur J Immunol; 2010 Nov; 40(11):3220-5. PubMed ID: 20957749
[TBL] [Abstract][Full Text] [Related]
18. Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death.
Brenner D; Golks A; Kiefer F; Krammer PH; Arnold R
EMBO J; 2005 Dec; 24(24):4279-90. PubMed ID: 16341093
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 7H-Pyrrolo[2,3-d]pyrimidine Derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.
Wu F; Li H; An Q; Sun Y; Yu J; Cao W; Sun P; Diao X; Meng L; Xu S
Eur J Med Chem; 2023 Jun; 254():115355. PubMed ID: 37062169
[TBL] [Abstract][Full Text] [Related]
20. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
